Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

ClinicalTrials.gov ID: NCT00004054

Public ClinicalTrials.gov record NCT00004054. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 8:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Protocol of Androgen Suppression (AS) and Radiation Therapy (RT) vs AS and RT Followed by Chemotherapy With Paclitaxel, Estramustine, and Etoposide (TEE) for Localized, High-Risk, Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Hormones can stimulate the production of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens. Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether hormone therapy plus radiation therapy is more effective with or without combination chemotherapy for prostate cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of hormone therapy plus radiation therapy with or without combination chemotherapy in treating patients who have prostate cancer.

Study identification

NCT ID
NCT00004054
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
397 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 1999
Primary completion
Mar 31, 2010
Completion
Oct 31, 2013
Last update posted
Oct 21, 2020

2000 – 2013

United States locations

U.S. sites
52
U.S. states
22
U.S. cities
46
Facility City State ZIP Site status
University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama 35294-3300
Foundation for Cancer Research and Education Phoenix Arizona 85013
Mount Diablo Medical Center Concord California 94524-4110
Sutter Health Western Division Cancer Research Group Greenbrae California 94904
CCOP - Santa Rosa Memorial Hospital Santa Rosa California 95403
University of Colorado Cancer Center at University of Colorado Health Sciences Center Denver Colorado 80010
Baptist Hospital of Miami Miami Florida 33176-2197
Lutheran General Cancer Care Center Park Ridge Illinois 60068
Methodist Cancer Center at Methodist Hospital Indianapolis Indiana 46206-1367
Ball Memorial Hospital Cancer Center Muncie Indiana 47303-3499
Markey Cancer Center at University of Kentucky Chandler Medical Center Lexington Kentucky 40536-0293
Mary Bird Perkins Cancer Center Baton Rouge Louisiana 70809
CCOP - Ochsner New Orleans Louisiana 70121
Anne Arundel Oncology Center Annapolis Maryland 21401
Greater Baltimore Medical Center and Cancer Center Baltimore Maryland 21204
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109-0010
West Michigan Cancer Center Kalamazoo Michigan 49007
Marquette General Hospital Marquette Michigan 49855
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416
Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia Missouri 65203
CCOP - Southern Nevada Cancer Research Foundation Las Vegas Nevada 89106
Veterans Affairs Medical Center - East Orange East Orange New Jersey 07019
Monmouth Medical Center Long Branch New Jersey 07740-6395
South Jersey Regional Cancer Center Millville New Jersey 08332
Atlantic City Medical Center Pomona New Jersey 08240
Fox Chase Cancer Center at St. Francis Medical Center Trenton New Jersey 08629
CCOP - North Shore University Hospital Manhasset New York 11030
Herbert Irving Comprehensive Cancer Center at Columbia University New York New York 10032
Akron General Medical Center Akron Ohio 44302
Akron City Hospital Akron Ohio 44304
CCOP - Columbus Columbus Ohio 43206
Arthur G. James Cancer Hospital - Ohio State University Columbus Ohio 43210-1240
CCOP - Dayton Dayton Ohio 45429
CCOP - Toledo Community Hospital Toledo Ohio 43623-3456
John and Dorothy Morgan Cancer Center at Lehigh Valley Hospital Allentown Pennsylvania 18105
St. Luke's Hospital Cancer Center Bethlehem Pennsylvania 18015
Delaware County Memorial Hospital Drexel Hill Pennsylvania 19026
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia Philadelphia Pennsylvania 19107-5541
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Albert Einstein Cancer Center Philadelphia Pennsylvania 19141-3098
CCOP - MainLine Health Wynnewood Pennsylvania 19096
Wellspan Health - York Cancer Center York Pennsylvania 17403
University of Texas - MD Anderson Cancer Center Houston Texas 77030-4009
LDS Hospital Salt Lake City Utah 84143
Dixie Regional Medical Center St. George Utah 84770
University Cancer Center at University of Washington Medical Center Seattle Washington 98195-6043
CCOP - St. Vincent Hospital Cancer Center, Green Bay Green Bay Wisconsin 54301
St. Vincent Hospital Green Bay Wisconsin 54307-3508
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center La Crosse Wisconsin 54601
St. Luke's Medical Center Milwaukee Wisconsin 53215
Medical College of Wisconsin Cancer Center Milwaukee Wisconsin 53226
All Saints Cancer Center at All Saints Healthcare Racine Wisconsin 53405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

Recently updated Prostate Cancer trials

Other public records listing Prostate Cancer. Sorted by last update posted; newest first. Not a recommendation.

All Prostate Cancer trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00004054, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 21, 2020 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00004054 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →